Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs LINCOLN PHAR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES LINCOLN PHAR ZIM LABORATORIES/
LINCOLN PHAR
 
P/E (TTM) x 28.4 13.4 211.2% View Chart
P/BV x 2.3 2.3 99.5% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ZIM LABORATORIES   LINCOLN PHAR
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
LINCOLN PHAR
Mar-23
ZIM LABORATORIES/
LINCOLN PHAR
5-Yr Chart
Click to enlarge
High Rs388380 102.1%   
Low Rs67255 26.5%   
Sales per share (Unadj.) Rs81.8254.8 32.1%  
Earnings per share (Unadj.) Rs5.036.4 13.8%  
Cash flow per share (Unadj.) Rs8.641.0 21.0%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs41.1250.9 16.4%  
Shares outstanding (eoy) m48.7320.03 243.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.2 223.5%   
Avg P/E ratio x45.48.7 520.6%  
P/CF ratio (eoy) x26.57.7 341.8%  
Price / Book Value ratio x5.51.3 437.7%  
Dividend payout %04.1 0.0%   
Avg Mkt Cap Rs m11,0966,358 174.5%   
No. of employees `000NANA-   
Total wages/salary Rs m493932 52.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,9855,103 78.1%  
Other income Rs m64225 28.5%   
Total revenues Rs m4,0495,328 76.0%   
Gross profit Rs m520892 58.3%  
Depreciation Rs m17592 190.6%   
Interest Rs m5620 274.6%   
Profit before tax Rs m3541,005 35.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m109276 39.6%   
Profit after tax Rs m244729 33.5%  
Gross profit margin %13.017.5 74.6%  
Effective tax rate %30.927.4 112.5%   
Net profit margin %6.114.3 42.9%  
BALANCE SHEET DATA
Current assets Rs m1,9093,911 48.8%   
Current liabilities Rs m1,108962 115.2%   
Net working cap to sales %20.157.8 34.8%  
Current ratio x1.74.1 42.4%  
Inventory Days Days19128 15.2%  
Debtors Days Days872975 89.5%  
Net fixed assets Rs m1,5692,454 63.9%   
Share capital Rs m487200 243.3%   
"Free" reserves Rs m1,5164,824 31.4%   
Net worth Rs m2,0035,025 39.9%   
Long term debt Rs m2460-   
Total assets Rs m3,4796,365 54.7%  
Interest coverage x7.350.5 14.5%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.10.8 142.9%   
Return on assets %8.611.8 73.3%  
Return on equity %12.214.5 84.1%  
Return on capital %18.220.4 89.2%  
Exports to sales %81.157.4 141.1%   
Imports to sales %12.22.0 620.3%   
Exports (fob) Rs m3,2302,931 110.2%   
Imports (cif) Rs m485100 484.4%   
Fx inflow Rs m3,2812,931 111.9%   
Fx outflow Rs m485100 484.4%   
Net fx Rs m2,7962,831 98.8%   
CASH FLOW
From Operations Rs m375393 95.6%  
From Investments Rs m-362-366 98.8%  
From Financial Activity Rs m5-45 -12.1%  
Net Cashflow Rs m30-19 -159.4%  

Share Holding

Indian Promoters % 33.3 49.8 66.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.3 -  
FIIs % 0.0 3.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 50.2 132.9%  
Shareholders   17,342 29,316 59.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ZIM LABORATORIES vs LINCOLN PHAR

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ZIM LABORATORIES vs LINCOLN PHAR Share Price Performance

Period ZIM LABORATORIES LINCOLN PHAR S&P BSE HEALTHCARE
1-Day 0.10% -1.24% 1.18%
1-Month -12.39% -14.71% -0.75%
1-Year 31.31% 77.45% 61.82%
3-Year CAGR 10.39% 38.03% 18.16%
5-Year CAGR -5.47% 22.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the ZIM LABORATORIES share price and the LINCOLN PHAR share price.

Moving on to shareholding structures...

The promoters of ZIM LABORATORIES hold a 33.3% stake in the company. In case of LINCOLN PHAR the stake stands at 49.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ZIM LABORATORIES and the shareholding pattern of LINCOLN PHAR.

Finally, a word on dividends...

In the most recent financial year, ZIM LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

LINCOLN PHAR paid Rs 1.5, and its dividend payout ratio stood at 4.1%.

You may visit here to review the dividend history of ZIM LABORATORIES, and the dividend history of LINCOLN PHAR.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.